Carl Zeiss Meditec AG (CZMWF)
USD 65.07
(17.14%)
USD 65.07
(17.14%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 133.88 Million EUR | 25.93% |
| 2022 | 106.31 Million EUR | 4.3% |
| 2021 | 101.92 Million EUR | 91.98% |
| 2020 | 53.09 Million EUR | 23.97% |
| 2019 | 42.82 Million EUR | 485.0% |
| 2018 | 7.32 Million EUR | 144.44% |
| 2017 | 2.99 Million EUR | -51.11% |
| 2016 | 6.12 Million EUR | -31.39% |
| 2015 | 8.92 Million EUR | -14.27% |
| 2014 | 10.41 Million EUR | -12.98% |
| 2013 | 11.96 Million EUR | -28.55% |
| 2012 | 16.75 Million EUR | 92.29% |
| 2011 | 8.71 Million EUR | -47.77% |
| 2010 | 16.68 Million EUR | -1.33% |
| 2009 | 16.9 Million EUR | -8.85% |
| 2008 | 18.54 Million EUR | -43.42% |
| 2007 | 32.77 Million EUR | -30.9% |
| 2006 | 47.43 Million EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | 0.0% |
| 2024 Q2 | 120.16 Million EUR | 0.0% |
| 2024 Q3 | - EUR | 0.0% |
| 2023 Q2 | 134.52 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q4 | 133.88 Million EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 133.88 Million EUR | 25.93% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q4 | 106.31 Million EUR | 0.0% |
| 2022 FY | 106.31 Million EUR | 4.3% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q2 | 101.07 Million EUR | 0.0% |
| 2021 Q2 | 102.02 Million EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 101.92 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 FY | 101.92 Million EUR | 91.98% |
| 2020 Q4 | 53.09 Million EUR | 0.0% |
| 2020 FY | 53.09 Million EUR | 23.97% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 38.22 Million EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 42.82 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 51.37 Million EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 42.82 Million EUR | 485.0% |
| 2018 FY | 7.32 Million EUR | 144.44% |
| 2018 Q4 | 7.32 Million EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q2 | 1.44 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 2.99 Million EUR | 0.0% |
| 2017 Q2 | 4.84 Million EUR | 0.0% |
| 2017 FY | 2.99 Million EUR | -51.11% |
| 2017 Q3 | - EUR | -100.0% |
| 2016 Q1 | 8.44 Million EUR | -5.45% |
| 2016 Q4 | 6.12 Million EUR | -13.49% |
| 2016 Q3 | 7.08 Million EUR | -6.77% |
| 2016 FY | 6.12 Million EUR | -31.39% |
| 2016 Q2 | 7.59 Million EUR | -10.03% |
| 2015 Q4 | 8.92 Million EUR | -7.37% |
| 2015 FY | 8.92 Million EUR | -14.27% |
| 2015 Q2 | 10.7 Million EUR | 5.36% |
| 2015 Q1 | 10.16 Million EUR | -2.45% |
| 2015 Q3 | 9.63 Million EUR | -9.96% |
| 2014 FY | 10.41 Million EUR | -12.98% |
| 2014 Q4 | 10.41 Million EUR | 2.16% |
| 2014 Q2 | 10.63 Million EUR | -5.08% |
| 2014 Q1 | 11.2 Million EUR | -6.42% |
| 2014 Q3 | 10.19 Million EUR | -4.1% |
| 2013 Q3 | 12.8 Million EUR | -5.34% |
| 2013 Q4 | 11.96 Million EUR | -6.56% |
| 2013 FY | 11.96 Million EUR | -28.55% |
| 2013 Q1 | 13.64 Million EUR | -18.57% |
| 2013 Q2 | 13.53 Million EUR | -0.8% |
| 2012 FY | 16.75 Million EUR | 92.29% |
| 2012 Q4 | 16.75 Million EUR | 10.72% |
| 2012 Q1 | 15.59 Million EUR | 79.05% |
| 2012 Q2 | 14.75 Million EUR | -5.41% |
| 2012 Q3 | 15.13 Million EUR | 2.54% |
| 2011 Q1 | 16.65 Million EUR | -0.17% |
| 2011 Q4 | 8.71 Million EUR | -40.96% |
| 2011 FY | 8.71 Million EUR | -47.77% |
| 2011 Q3 | 14.75 Million EUR | -5.42% |
| 2011 Q2 | 15.6 Million EUR | -6.31% |
| 2010 Q4 | 16.68 Million EUR | -11.64% |
| 2010 FY | 16.68 Million EUR | -1.33% |
| 2010 Q3 | 18.87 Million EUR | 7.32% |
| 2010 Q2 | 17.59 Million EUR | 4.19% |
| 2010 Q1 | 16.88 Million EUR | -0.13% |
| 2009 Q4 | 16.9 Million EUR | 0.0% |
| 2009 FY | 16.9 Million EUR | -8.85% |
| 2008 FY | 18.54 Million EUR | -43.42% |
| 2007 FY | 32.77 Million EUR | -30.9% |
| 2006 FY | 47.43 Million EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 81.017% |
| Ansell Limited | 706.6 Million USD | 81.053% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -497.37% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -21320.8% |
| ConvaTec Group Plc | 1.22 Billion USD | 89.073% |
| ConvaTec Group Plc | 1.22 Billion USD | 89.088% |
| Encision Inc. | 67.33 Thousand USD | -198723.809% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -34870.497% |
| LifePoint, Inc. | 151.73 Thousand USD | -88133.356% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -2624.461% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -21669.106% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -74293.07% |
| SmileDirectClub, Inc. | 849.37 Million USD | 84.238% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 36.484% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -276003.859% |
| Vasamed, Inc. | 18.95 Thousand USD | -706390.765% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -724829.608% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -34189.08% |